Dr. DeSimone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Fairfax, VA 22031Phone+1 571-472-4724Fax+1 571-472-0241
Education & Training
- Brigham and Womens HospitalFellowship, Cutaneous Oncology, 2011 - 2012
- MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2006 - 2010
- MedStar Health/Washington Hospital CenterResidency, Internal Medicine/Dermatology, 2006 - 2010
- Virginia Commonwealth University School of MedicineClass of 2005
Certifications & Licensure
- VA State Medical License 2005 - 2026
- MD State Medical License 2010 - 2018
- DC State Medical License 2005 - 2014
- MA State Medical License 2011 - 2014
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Transplantation and Cellular Therapy. 2024-11-01 - 1 citationsMerkel cell carcinoma.Sach Thakker, Suraj Venna, Micah Belzberg, Sekwon Jang, Jennifer DeSimone
Journal of the American Academy of Dermatology. 2024-09-01 - Managing large cutaneous squamous cell carcinoma with programmed cell death protein 1 inhibitor monotherapy: Real-world experience at a single center.Sach Thakker, Mairead R Baker, Jafar Al-Mondhiry, Sekwon Jang, Jennifer A DeSimone
JAAD International. 2024-09-01
Other
- Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinomaDeSimone JA, Schmults CD, Karia PS
http://www.uptodate.com/contents/recognition-and-management-of-high-risk-aggressive-cutaneous-squamo
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
- Expert Panel Develops Guidance to Manage Skin Cancer in Organ Transplant PatientsOctober 11th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: